Search

Your search keyword '"Quintini, Gerlando"' showing total 26 results
Start Over Author "Quintini, Gerlando"
26 results on '"Quintini, Gerlando"'

2. High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study

Author

Balduini, Carlo L., Gugliotta, Luigi, Luppi, Mario, Laurenti, Luca, Klersy, Catherine, Pieresca, Carla, Quintini, Gerlando, Iuliano, Francesco, Re, Rossana, Spedini, Pierangelo, Vianelli, Nicola, Zaccaria, Alfonso, Pogliani, Enrico Maria, Musso, Roberto, Bobbio Pallavicini, Enrico, Quarta, Giovanni, Galieni, Piero, Fragasso, Alberto, Casella, Gianluca, Noris, Patrizia, Ascari, Edoardo, and The Italian TTP Study Group

Published
2010
Full Text
View/download PDF

15. Absolute lymphocyte count is unrelated to overall survival in newly diagnosed elderly patients with multiple myeloma treated with immunomodulatory drugs

Author

Napolitano, Mariasanta, primary, Saccullo, Giorgia, additional, Bono, Roberto, additional, Branca, Antonio, additional, Cangialosi, Clotilde, additional, Mancuso, Salvatrice, additional, Raso, Simona, additional, Quintini, Gerlando, additional, Lipari, Maria Grazia, additional, Fabbiano, Francesco, additional, Specchia, Giorgina, additional, Dolce, Alberto, additional, Di Raimondo, Francesco, additional, and Siragusa, Sergio, additional

Published
2014
Full Text
View/download PDF

16. Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study

Author

Zinzani, Pier Luigi, primary, Pellegrini, Cinzia, additional, Merla, Emanuela, additional, Ballerini, Filippo, additional, Fabbri, Alberto, additional, Guarini, Attilio, additional, Pavone, Vincenzo, additional, Quintini, Gerlando, additional, Puccini, Benedetta, additional, Vigliotti, Maria Luigia, additional, Stefoni, Vittorio, additional, Derenzini, Enrico, additional, Broccoli, Alessandro, additional, Gandolfi, Letizia, additional, Quirini, Federica, additional, Casadei, Beatrice, additional, Argnani, Lisa, additional, and Baccarani, Michele, additional

Published
2012
Full Text
View/download PDF

18. Bortezomib as Front-Line Therapy in Primary Plasma Cell Leukemia

Author

Pietrantuono, Giuseppe, primary, Guariglia, Roberto, primary, Villani, Oreste, primary, Martorelli, Maria Carmen, primary, D’Auria, Fiorella, primary, Zonno, Antonia, primary, Lerose, Rosa, primary, Fioritoni, Giuseppe, primary, Zamagni, Elena, primary, Rossini, Fausto, primary, Filardi, Nunzio, primary, Pagano, Livio, primary, Musuraca, Gerardo, primary, Pitini, Vincenzo, primary, Quintini, Gerlando, primary, Falcone, Antonietta, primary, Bringhen, Sara, primary, Palumbo, Antonio, primary, and Musto, Pellegrino, primary

Published
2008
Full Text
View/download PDF

21. Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study.

Author

Zinzani, Pier Luigi, Pellegrini, Cinzia, Merla, Emanuela, Ballerini, Filippo, Fabbri, Alberto, Guarini, Attilio, Pavone, Vincenzo, Quintini, Gerlando, Puccini, Benedetta, Vigliotti, Maria Luigia, Stefoni, Vittorio, Derenzini, Enrico, Broccoli, Alessandro, Gandolfi, Letizia, Quirini, Federica, Casadei, Beatrice, Argnani, Lisa, and Baccarani, Michele

Abstract

Current treatments for non-Hodgkin lymphomas are not optimally effective. Among new agents, bortezomib seems to play a pivotal role in the regulation of several cell pathways involved in the development of lymphomas. After results were obtained with clinical trials, we aimed to observe treatment with bortezomib in everyday clinical practice. We performed a multicenter retrospective analysis to assess the efficacy of bortezomib in heavily pretreated (median number of previous therapies 4, range 2-6) lymphoma patients in an off-label setting. Bortezomib therapy was scheduled for 4-6 cycles (1.3 mg/m2 biweekly). Data from 50 patients were collected: 22% had a complete remission, 26% obtained a partial response and the remaining 52% was non-responder. According to histotype, we observed an overall response rate (ORR) of 51.6% in mantle cell lymphomas, an ORR of 60% among follicular lymphoma patients, and an ORR of 50% in the indolent nonfollicular lymphomas. None of diffuse large B-cell lymphoma patients obtained a response. Extra-hematological toxicity was really mild, and peripheral neuropathy occurred in only 5 patients; hematological toxicity was grades 3-4 thrombocytopenia in nine patients and grades 3-4 neutropenia in only three patients. In conclusion, treatment with bortezomib as single agent resulted safe and effective in a subset of heavily pretreated lymphoma patients with usually poor outcome. New future hypotheses of investigation are indicated. Copyright © 2012 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]

Published
2013
Full Text
View/download PDF

23. Absolute lymphocyte count is unrelated to overall survival in newly diagnosed elderly patients with multiple myeloma treated with immunomodulatory drugs.

Author

Napolitano, Mariasanta, Saccullo, Giorgia, Bono, Roberto, Branca, Antonio, Cangialosi, Clotilde, Mancuso, Salvatrice, Raso, Simona, Quintini, Gerlando, Lipari, Maria Grazia, Fabbiano, Francesco, Specchia, Giorgina, Dolce, Alberto, Di Raimondo, Francesco, and Siragusa, Sergio

Subjects
LYMPHOCYTE count, MULTIPLE myeloma treatment, IMMUNOLOGICAL adjuvants
Abstract

A letter to the editor is presented which discusses a study of the role of absolute lymphocyte count (ALC) at diagnosis in older patients with multiple myeloma (MM) who are treated with immunomodulatory drugs (IMIDs) and not qualified for allogeneic stem cell transplant (ASCT).

Published
2015
Full Text
View/download PDF

25. Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndrome.

Author

Caramazza D, Quintini G, Abbene I, Coco LL, Malato A, Di Trapani R, Saccullo G, Pizzo G, Palazzolo R, Barone R, Mazzola G, Rizzo S, Ragonese P, Aridon P, Abbadessa V, and Siragusa S

Subjects
ADAM Proteins blood, ADAMTS13 Protein, Adolescent, Adult, Female, Humans, Immunologic Factors therapeutic use, Male, Middle Aged, Purpura, Thrombotic Thrombocytopenic drug therapy, Rituximab, Salvage Therapy methods, Treatment Outcome, Antibodies, Monoclonal, Murine-Derived therapeutic use
Published
2010
Full Text
View/download PDF

26. Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin.

Author

Iannitto E, Barbera V, Quintini G, Cirrincione S, and Leone M

Subjects
Adult, Combined Modality Therapy, Hematopoietic Stem Cell Transplantation, Humans, Liver Neoplasms surgery, Lymphoma, T-Cell immunology, Lymphoma, T-Cell surgery, Male, Splenic Neoplasms surgery, Immunosuppressive Agents therapeutic use, Liver Neoplasms drug therapy, Lymphoma, T-Cell drug therapy, Pentostatin therapeutic use, Receptors, Antigen, T-Cell, gamma-delta, Splenic Neoplasms drug therapy
Published
2002
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results